GSK3B and neoplasm: In our study, overexpressed AQP9 reduced the levels of DVL2, p-GSK-3β, CyclinD1 and β-catenin, suggesting that AQP9 could be a novel tumor suppressor by suppressing Wnt/β-catenin signaling pathway.